Laser device company Chromogenex lists on London's AIM (Alternative Investment Market), raises pounds2m:
This article was originally published in Clinica
Chromogenex, the UK medical and aesthetic laser device company formerly known as EUPhotonics, has listed on London's Alternative Investment Market (AIM). The company raised £2m ($3.6m), and floated with a market capitalisation of £6.51m. Its main products are the Chromolite intense pulsed light treatment for removing hair, skin pigmentation and thread veins, and the Nlite pulsed-dye laser system for vascular lesions, acne and psoriasis.
You may also be interested in...
Companion diagnostics are needed increasingly by pharma companies to justify the safety and effectiveness of their products. With specific first-time EU regulation of these products within sight – and urgently needed – is there a risk of delays to these products being able to demonstrate compliance?